Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration.
about
Diabetic macular edema in proliferative stage treated with anti-vascular endothelial growth factor agent and triamcinolone acetonide by laser-based strategiesOcular Blood Flow Autoregulation Mechanisms and Methods.Optical Coherence Tomography and the Development of Antiangiogenic Therapies in Neovascular Age-Related Macular Degeneration.Investigational drugs for retinal vein occlusion.New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein OcclusionClinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis.Immunoglobulin-like domain 4-mediated ligand-independent dimerization triggers VEGFR-2 activation in HUVECs and VEGFR2-positive breast cancer cells.Observation of optic disc neovascularization using OCT angiography in proliferative diabetic retinopathy after intravitreal conbercept injections.
P2860
Q33912480-AC38950A-FDC0-467A-83FE-3E5BF3169A2BQ36245455-A35C6C98-F287-43D3-B1EA-3761D19A0E2EQ37143095-1668D31F-E6C3-4CFA-98D2-96E666B26544Q38827602-D2D904C0-78B1-4667-A301-8C460F093EEEQ38848800-BF23BBF5-3D5F-4DE9-9716-AEA8621EDAA0Q49223108-C9FDD84B-FCB7-4F48-BDDF-0BEEE7D83CF9Q52700516-7AD4E866-3A3F-43F7-B31A-67796F14C51BQ55208760-E5DF0C00-DF20-4F38-9825-02BF81EF80B6
P2860
Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration.
@en
Conbercept
@nl
type
label
Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration.
@en
Conbercept
@nl
prefLabel
Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration.
@en
Conbercept
@nl
P2860
P1476
Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration
@en
P2093
Thanh T Nguyen
P2860
P304
P356
10.1586/17512433.2015.1075879
P407
P577
2015-08-10T00:00:00Z